Ironwood Pharmaceuticals Price Target Doubles to $1.84, Analysts Bullish Despite 41.53% Decline from Latest Closing Price.

Ironwood Pharmaceuticals' average one-year price target has been revised to $1.84/share, a 89.47% increase from the prior estimate of $0.97/share. The price target represents a 41.53% decrease from the latest closing price of $3.14/share. The average portfolio weight of all funds dedicated to IRWD is 0.05%, an increase of 26.69%. Total shares owned by institutions decreased by 6.89% to 162,412K shares. The put/call ratio of IRWD is 0.12, indicating a bullish outlook.